Thursday, April 18, 2024
HomeFundingUAE based Mubadala Acquires KELIX bio to Promote Innovation in Healthcare

UAE based Mubadala Acquires KELIX bio to Promote Innovation in Healthcare

Mubadala Investment Company, an Abu Dhabi sovereign investor, has entered into a definitive agreement to acquire KELIX bio, a specialty pharmaceutical company that specializes in delivering complex generics across emerging markets.

The UAE hopes to become a global leader in this field, support economic diversification, and further strengthen its position in the industry.

Read also – Alpha Token Capital Makes An Investment in Carrieverse

Since its founding in November 2020, KELIX Bio has successfully acquired manufacturing companies in Egypt, Morocco, India, and Malta in order to expand its product line of injectable and oral formulations, which covers a wide range of therapeutic areas such as diabetes, oncology, cardiology, and central nervous systems.

The acquisition is expected to improve UAE’s reputation in the bio sciences on a worldwide scale. The decision is in line with Mubadala’s objective to establish the UAE as a major player in the global life sciences industry, as Kelix Bio specializes in pertinent therapy areas and has a leadership team with extensive expertise in buy-and-build methods worldwide.

Read also – India’s Ultrahuman Secures $35M in Equity and debt investment

Dr. Bakheet Al Katheeri, Chief Executive Officer of Mubadala’s UAE Investments Platform, said, “In line with our role as a responsible investor, today’s acquisition is testament to the role Mubadala continues to play in accelerating the nation’s economic diversification through our portfolio companies and national champions.”

He added: “This partnership marks a key milestone in further advancing Mubadala’s position in the life sciences sector, to deliver important long-term socio-economic returns for our nation including improved healthcare, drug security, job creation and GDP impact.”

About KELIX bio

KELIX bio is a buy-and-build specialty generic company with an emphasis on emerging markets that aims to outperform its competitors through cost leadership and innovation. The goal of KELIX bio is to create and market reasonably priced specialized goods in areas that have historically been without access to these kinds of drugs.

About Mubadala

Mubadala Investment Company,  is a global, sovereign investor with an entrepreneurial spirit, is to generate long-term profits for Abu Dhabi.

- Advertisement -
RELATED ARTICLES
- Advertisment -

Most Popular